标题
Antibiotics in the clinical pipeline at the end of 2015
作者
关键词
-
出版物
JOURNAL OF ANTIBIOTICS
Volume 70, Issue 1, Pages 3-24
出版商
Springer Nature
发表日期
2016-06-30
DOI
10.1038/ja.2016.72
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Impact of Surotomycin on the Gut Microbiota of Healthy Volunteers in a Phase 1 Clinical Trial
- (2016) Diane M. Citron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Alternatives to antibiotics—a pipeline portfolio review
- (2016) Lloyd Czaplewski et al. LANCET INFECTIOUS DISEASES
- Ceftolozane/Tazobactam
- (2015) Allana J. Sucher et al. ANNALS OF PHARMACOTHERAPY
- Structure-Activity Relationship of the Aminomethylcyclines and the Discovery of Omadacycline
- (2015) Laura Honeyman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Eravacycline (TP-434) Is ActiveIn Vitroagainst Biofilms Formed by Uropathogenic Escherichia coli
- (2015) Trudy H. Grossman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Ceftolozane Alone and in Combination with Tazobactam against Extended-Spectrum-β-Lactamase-Harboring Enterobacteriaceae
- (2015) Maria J. B. Melchers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamic Profile of GSK2140944 against Methicillin-Resistant Staphylococcus aureus in a Murine Lung Infection Model
- (2015) Wonhee So et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High Efficacy of Finafloxacin on Helicobacter pylori Isolates at pH 5.0 Compared with That of Other Fluoroquinolones
- (2015) Jung Won Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mode of Action and Bactericidal Properties of Surotomycin against Growing and Nongrowing Clostridium difficile
- (2015) Mohammed Zahidul Alam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effects of Surotomycin on Clostridium difficile Viability and Toxin ProductionIn Vitro
- (2015) Laurent Bouillaut et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Debio1452, a FabI Inhibitor with Potent Activity against Staphylococcus aureus and Coagulase-Negative Staphylococcus spp., Including Multidrug-Resistant Strains
- (2015) Robert K. Flamm et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VivoActivities of Simulated Human Doses of Cefepime and Cefepime-AAI101 against Multidrug-Resistant Gram-Negative Enterobacteriaceae
- (2015) Jared L. Crandon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- SQ109, a New Drug Lead for Chagas Disease
- (2015) Phercyles Veiga-Santos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mutations in Genes for the F420Biosynthetic Pathway and a Nitroreductase Enzyme Are the Primary Resistance Determinants in SpontaneousIn Vitro-Selected PA-824-Resistant Mutants of Mycobacterium tuberculosis
- (2015) Hana L. Haver et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroAntimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains
- (2015) Naoki Kohira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic
- (2015) Steven D. Burdette et al. CLINICAL INFECTIOUS DISEASES
- Editorial overview: Anti-infectives: Current challenges and unmet needs in antimicrobial therapy
- (2015) Federico Pea CURRENT OPINION IN PHARMACOLOGY
- The global challenge of new classes of antibacterial agents: an industry perspective
- (2015) Prabhavathi Fernandes CURRENT OPINION IN PHARMACOLOGY
- Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens
- (2015) George G. Zhanel et al. DRUGS
- Finafloxacin: First Global Approval
- (2015) Kate McKeage DRUGS
- Plazomicin: an investigational therapy for the treatment of urinary tract infections
- (2015) Ilias Karaiskos et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Safety, tolerability and pharmacokinetics of AFN–1252 administered as immediate release tablets in healthy subjects
- (2015) Barry Hafkin et al. Future Microbiology
- Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacy
- (2015) Françoise Van Bambeke Future Microbiology
- In vitro bactericidal activity of aminoglycosides, including the next-generation drug plazomicin, against Brucella spp.
- (2015) Steven C. Olsen et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The new tuberculosis drug Perchlozone® shows cross-resistance with thiacetazone
- (2015) Pooja Gopal et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitroantimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria
- (2015) Akinobu Ito et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam ‘enhancer’
- (2015) Akihiro Morinaka et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Inhibition ofNeisseria gonorrhoeaeType II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914
- (2015) Gunther Kern et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery and development of surotomycin for the treatment of Clostridium difficile
- (2015) Victoria Knight-Connoni et al. JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
- Structure–Activity Relationship Studies of a Series of Semisynthetic Lipopeptides Leading to the Discovery of Surotomycin, a Novel Cyclic Lipopeptide Being Developed for the Treatment of Clostridium difficile-Associated Diarrhea
- (2015) Ning Yin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI)
- (2015) Florian M Wagenlehner et al. LANCET
- Erratum: A new antibiotic kills pathogens without detectable resistance
- (2015) Losee L. Ling et al. NATURE
- Mining the microbial dark matter
- (2015) Corie Lok NATURE
- A community-based approach to new antibiotic discovery
- (2015) Matthew A. Cooper NATURE REVIEWS DRUG DISCOVERY
- ESKAPEing the labyrinth of antibacterial discovery
- (2015) Ruben Tommasi et al. NATURE REVIEWS DRUG DISCOVERY
- Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
- (2015) David Brown NATURE REVIEWS DRUG DISCOVERY
- Delamanid for Extensively Drug-Resistant Tuberculosis
- (2015) Rajesh Gupta et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preface
- (2015) R. M. Anderson PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Surveillance of antibiotic resistance
- (2015) A. P. Johnson PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Tackling the threat of antimicrobial resistance: from policy to sustainable action
- (2015) L. J. Shallcross et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Antimicrobial resistance in humans, livestock and the wider environment
- (2015) M. Woolhouse et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- The livestock reservoir for antimicrobial resistance: a personal view on changing patterns of risks, effects of interventions and the way forward
- (2015) F. M. Aarestrup PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- AFN-1252 is a potent inhibitor of enoyl-ACP reductase fromBurkholderia pseudomallei-Crystal structure, mode of action, and biological activity
- (2015) Krishnamurthy Narasimha Rao et al. PROTEIN SCIENCE
- The drug push
- (2015) K. Servick SCIENCE
- Nonmedical Uses of Antibiotics: Time to Restrict Their Use?
- (2015) Richard William Meek et al. PLOS BIOLOGY
- Oxa, Thia, Heterocycle, and Carborane Analogues of SQ109: Bacterial and Protozoal Cell Growth Inhibitors
- (2015) Kai Li et al. ACS Infectious Diseases
- Helping Chemists Discover New Antibiotics
- (2015) Mark A. T. Blaskovich et al. ACS Infectious Diseases
- Therapeutic strategies to combat antibiotic resistance
- (2014) Benjamin D. Brooks et al. ADVANCED DRUG DELIVERY REVIEWS
- Novel Insights into the Mechanism of Inhibition of MmpL3, a Target of Multiple Pharmacophores in Mycobacterium tuberculosis
- (2014) Wei Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VivoAntibacterial Activity of MRX-I, a New Oxazolidinone
- (2014) Cong-Ran Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of the New Fluoroketolide Solithromycin (CEM-101) against Macrolide-Resistant and -Susceptible Mycoplasma genitalium Strains
- (2014) Jørgen Skov Jensen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroandIn VivoActivities of the Nitroimidazole TBA-354 against Mycobacterium tuberculosis
- (2014) A. M. Upton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter, Double-Blind, Randomized, Phase II Trial To Assess the Safety and Efficacy of Ceftolozane-Tazobactam plus Metronidazole Compared with Meropenem in Adult Patients with Complicated Intra-Abdominal Infections
- (2014) Christopher Lucasti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenem-Resistant Klebsiella pneumoniae Strains Exhibit Diversity in Aminoglycoside-Modifying Enzymes, Which Exert Differing Effects on Plazomicin and Other Agents
- (2014) Reem Almaghrabi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Plazomicin against 5,015 Gram-Negative and Gram-Positive Clinical Isolates Obtained from Patients in Canadian Hospitals as Part of the CANWARD Study, 2011-2012
- (2014) A. Walkty et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- HighIn VitroActivity of the Novel Spiropyrimidinetrione AZD0914, a DNA Gyrase Inhibitor, against Multidrug-Resistant Neisseria gonorrhoeae Isolates Suggests a New Effective Option for Oral Treatment of Gonorrhea
- (2014) Susanne Jacobsson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contribution of the Nitroimidazoles PA-824 and TBA-354 to the Activity of Novel Regimens in Murine Models of Tuberculosis
- (2014) Rokeya Tasneen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- LTX-109 Is a Novel Agent for Nasal Decolonization of Methicillin-Resistant and -Sensitive Staphylococcus aureus
- (2014) Anna C. Nilsson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Confronting the challenges of discovery of novel antibacterial agents
- (2014) Sheo B. Singh BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Update on the antibiotic resistance crisis
- (2014) Gian Maria Rossolini et al. CURRENT OPINION IN PHARMACOLOGY
- Delamanid: A Review of Its Use in Patients with Multidrug-Resistant Tuberculosis
- (2014) Hannah A. Blair et al. DRUGS
- Nemonoxacin: First Global Approval
- (2014) Raewyn M. Poole DRUGS
- The potential role of nemonoxacin for treatment of common infections
- (2014) Chung-Hao Huang et al. EXPERT OPINION ON PHARMACOTHERAPY
- In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates
- (2014) David Landman et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Selection and characterisation of Staphylococcus aureus mutants with reduced susceptibility to the investigational oxazolidinone MRX-I
- (2014) Yanqin Huang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Glycopeptide antibiotics: Back to the future
- (2014) Mark S Butler et al. JOURNAL OF ANTIBIOTICS
- Determination of Disk Diffusion and MIC Quality Control Guidelines for GSK2140944, a Novel Bacterial Type II Topoisomerase Inhibitor Antimicrobial Agent
- (2014) J. E. Ross et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Lead Optimization of a Novel Series of Imidazo[1,2-a]pyridine Amides Leading to a Clinical Candidate (Q203) as a Multi- and Extensively-Drug-Resistant Anti-tuberculosis Agent
- (2014) Sunhee Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- New Potent Antibacterial Oxazolidinone (MRX-I) with an Improved Class Safety Profile
- (2014) Mikhail F. Gordeev et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antibiotic resistance sweeping developing world
- (2014) Sara Reardon NATURE
- Fraunhofer to mine Sanofi microbial collection
- (2014) Jeffrey L Fox NATURE BIOTECHNOLOGY
- Second MRSA antibiotic reaches the market
- (2014) Jeffrey L Fox NATURE BIOTECHNOLOGY
- Anti-cooperative ligand binding and dimerisation in the glycopeptide antibiotic dalbavancin
- (2014) Mu Cheng et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- In vitro activity of cadazolid against Clostridium difficile strains isolated from primary and recurrent infections in Stockholm, Sweden
- (2013) Mamun-Ur Rashid et al. ANAEROBE
- Combating Multidrug-Resistant Bacteria: Current Strategies for the Discovery of Novel Antibacterials
- (2013) Kieron M. G. O'Connell et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- New β-lactam-β-lactamase inhibitor combinations in clinical development
- (2013) David M. Shlaes Annals of the New York Academy of Sciences
- Involvement of Fe Uptake Systems and AmpC β-Lactamase in Susceptibility to the Siderophore Monosulfactam BAL30072 in Pseudomonas aeruginosa
- (2013) Christian van Delden et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phase II Clinical Study of BC-3781, a Pleuromutilin Antibiotic, in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections
- (2013) W. T. Prince et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Nemonoxacin, a Novel Nonfluorinated Quinolone Antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae
- (2013) Kobkul Chotikanatis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Ozenoxacin against Quinolone-Susceptible and Quinolone-Resistant Gram-Positive Bacteria
- (2013) Y. López et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Human Simulated Studies of Aztreonam and Aztreonam-Avibactam To Evaluate Activity against Challenging Gram-Negative Organisms, Including Metallo-β-Lactamase Producers
- (2013) Jared L. Crandon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- N-Chloramines, a Promising Class of Well-Tolerated Topical Anti-Infectives
- (2013) Waldemar Gottardi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Perturbation of Staphylococcus aureus Gene Expression by the Enoyl-Acyl Carrier Protein Reductase Inhibitor AFN-1252
- (2013) Joshua B. Parsons et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Solithromycin against Erythromycin-Resistant Streptococcus agalactiae
- (2013) Giorgio Piccinelli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Solithromycin Inhibition of Protein Synthesis and Ribosome Biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae
- (2013) Ward Rodgers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Investigations of the Mode of Action and Resistance Development of Cadazolid, a New Antibiotic for Treatment of Clostridium difficile Infections
- (2013) Hans H. Locher et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
- (2013) J. A. Sutcliffe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroandIn VivoAntibacterial Evaluation of Cadazolid, a New Antibiotic for Treatment of Clostridium difficile Infections
- (2013) Hans H. Locher et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroandIn VivoAntibacterial Activities of Omadacycline, a Novel Aminomethylcycline
- (2013) A. B. Macone et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanism of Action of the Novel Aminomethylcycline Antibiotic Omadacycline
- (2013) Michael P. Draper et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Locations of the Hydrophobic Side Chains of Lipoglycopeptides Bound to the Peptidoglycan of Staphylococcus aureus
- (2013) Sung Joon Kim et al. BIOCHEMISTRY
- Fungicidal photodynamic effect of a twofold positively charged porphyrin againstCandida albicansplanktonic cells and biofilms
- (2013) Fernanda Pereira Gonzales et al. Future Microbiology
- Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections
- (2013) Philippe Prokocimer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Speculative strategies for new antibacterials: all roads should not lead to Rome
- (2013) Stuart Shapiro JOURNAL OF ANTIBIOTICS
- Antibiotics in the clinical pipeline in 2013
- (2013) Mark S Butler et al. JOURNAL OF ANTIBIOTICS
- Prospects for new antibiotics: a molecule-centered perspective
- (2013) Christopher T Walsh et al. JOURNAL OF ANTIBIOTICS
- Activity of biapenem (RPX2003) combined with the boronate -lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae
- (2013) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Combined effects of the siderophore monosulfactam BAL30072 and carbapenems on multidrug-resistant Gram-negative bacilli
- (2013) B. Hofer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of AFN-1252, a novel FabI inhibitor, againstStaphylococcus aureusin anin vitropharmacodynamic model simulating human pharmacokinetics
- (2013) Brian T Tsuji et al. JOURNAL OF CHEMOTHERAPY
- In vitroactivity (MICs and rate of kill) of AFN-1252, a novel FabI inhibitor, in the presence of serum and in combination with other antibiotics
- (2013) Nachum Kaplan et al. JOURNAL OF CHEMOTHERAPY
- Pharmacokinetics, pharmacodynamics and efficacy of novel FabI inhibitor AFN-1252 against MSSA and MRSA in the murine thigh infection model
- (2013) Mary A Banevicius et al. JOURNAL OF CHEMOTHERAPY
- BARDA to pick and choose next-generation antibiotics
- (2013) Gunjan Sinha NATURE BIOTECHNOLOGY
- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
- (2013) Kevin Pethe et al. NATURE MEDICINE
- Process R&D of Eravacycline: The First Fully Synthetic Fluorocycline in Clinical Development
- (2013) Magnus Ronn et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Mapping gene clusters within arrayed metagenomic libraries to expand the structural diversity of biomedically relevant natural products
- (2013) J. G. Owen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sources of Antimicrobial Resistance
- (2013) M. E. J. Woolhouse et al. SCIENCE
- In VitroActivities of LTX-109, a Synthetic Antimicrobial Peptide, against Methicillin-Resistant, Vancomycin-Intermediate, Vancomycin-Resistant, Daptomycin-Nonsusceptible, and Linezolid-Nonsusceptible Staphylococcus aureus
- (2012) Louis D. Saravolatz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- TD-1792 versus Vancomycin for Treatment of Complicated Skin and Skin Structure Infections
- (2012) Martin E. Stryjewski et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of a Novel Cyclic Lipopeptide, CB-183,315, against Resistant Clostridium difficile and Other Gram-Positive Aerobic and Anaerobic Intestinal Pathogens
- (2012) D. R. Snydman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- NVC-422 Inactivates Staphylococcus aureus Toxins
- (2012) A. Jekle et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of the New Fluoroketolide Solithromycin (CEM-101) against a Large Collection of Clinical Neisseria gonorrhoeae Isolates and International Reference Strains, Including Those with High-Level Antimicrobial Resistance: Potential Treatment Option for Gonorrhea?
- (2012) Daniel Golparian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Activity of the Investigational Pleuromutilin Compound BC-3781 Tested against Gram-Positive Organisms Commonly Associated with Acute Bacterial Skin and Skin Structure Infections
- (2012) Helio S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mode of Action,In VitroActivity, andIn VivoEfficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor
- (2012) Nachum Kaplan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic
- (2012) Trudy H. Grossman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin: Mechanism of Action
- (2012) George G. Zhanel et al. CLINICAL INFECTIOUS DISEASES
- Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
- (2012) George G Zhanel et al. Expert Review of Anti-Infective Therapy
- Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs)
- (2012) H. S. Sader et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumannii
- (2012) P. G. Higgins et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of Plazomicin (ACHN-490) against MDR clinical isolates ofKlebsiella pneumoniae, Escherichia coli, andEnterobacterspp. from Athens, Greece
- (2012) Irene Galani et al. JOURNAL OF CHEMOTHERAPY
- Avibactam is a covalent, reversible, non- -lactam -lactamase inhibitor
- (2012) D. E. Ehmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Are pleuromutilin antibiotics finally fit for human use?
- (2011) Rodger Novak Annals of the New York Academy of Sciences
- Antistaphylococcal Activity of TD-1792, a Multivalent Glycopeptide-Cephalosporin Antibiotic
- (2011) Johanne Blais et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivities of CB-183,315, Vancomycin, and Metronidazole against 556 Strains of Clostridium difficile, 445 Other Intestinal Anaerobes, and 56 Enterobacteriaceae Species
- (2011) Diane M. Citron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroSpectrum of Activity of Finafloxacin, a Novel, pH-Activated Fluoroquinolone, under Standard and Acidic Conditions
- (2011) Will Stubbings et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors
- (2011) Ken Coleman CURRENT OPINION IN MICROBIOLOGY
- Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent
- (2011) Weon Bin Im et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Substrate specificity of the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis responsible for the bioreductive activation of bicyclic nitroimidazoles
- (2011) Meera Gurumurthy et al. FEBS Journal
- In vitro activity of BAL30072 against Burkholderia pseudomallei
- (2011) Takehiko Mima et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to nemonoxacin, tigecycline, fosfomycin and other antimicrobial agents
- (2011) Meng-Shuian Hsu et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antibiotics in the clinical pipeline in 2011
- (2011) Mark S Butler et al. JOURNAL OF ANTIBIOTICS
- In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci
- (2011) I. Rodriguez-Avial et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Synthetic Antimicrobial Peptidomimetic (LTX 109): Stereochemical Impact on Membrane Disruption
- (2011) Johan Isaksson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fluorocyclines. 2. Optimization of the C-9 Side-Chain for Antibacterial Activity and Oral Efficacy
- (2011) Roger B. Clark et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fluorocyclines. 1. 7-Fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: A Potent, Broad Spectrum Antibacterial Agent
- (2011) Xiao-Yi Xiao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fix the antibiotics pipeline
- (2011) Matthew A. Cooper et al. NATURE
- A Concise Synthesis of a β-Lactamase Inhibitor
- (2011) Ian K. Mangion et al. ORGANIC LETTERS
- In Vitro and In Vivo Activities of LCB01-0371, a New Oxazolidinone
- (2010) J.-W. Jeong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanistic Studies of the Inactivation of TEM-1 and P99 by NXL104, a Novel Non- -Lactam -Lactamase Inhibitor
- (2010) T. Stachyra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative In Vitro Activities of Nemonoxacin (TG-873870), a Novel Nonfluorinated Quinolone, and Other Quinolones against Clinical Isolates
- (2010) T.-L. Lauderdale et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Investigation of the Potential for Mutational Resistance to XF-73, Retapamulin, Mupirocin, Fusidic Acid, Daptomycin, and Vancomycin in Methicillin-ResistantStaphylococcus aureusIsolates during a 55-Passage Study
- (2010) David J. Farrell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin Disrupts Membrane Integrity of Staphylococcus aureus and Vancomycin-Resistant Enterococci To Effect Rapid Bacterial Killing
- (2010) A. Belley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Properties of BAL30072, a Novel Siderophore Sulfactam with Activity against Multiresistant Gram-Negative Bacilli
- (2010) M. G. P. Page et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and Spectrum of the Neoglycoside ACHN-490
- (2010) J. B. Aggen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contrasting Effects of Acidic pH on the Extracellular and Intracellular Activities of the Anti-Gram-Positive Fluoroquinolones Moxifloxacin and Delafloxacin againstStaphylococcus aureus
- (2010) Sandrine Lemaire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Lipoglycopeptides
- (2010) George G. Zhanel et al. DRUGS
- Oritavancin: a novel lipoglycopeptide active against Gram-positive pathogens including multiresistant strains
- (2010) Emilio Bouza et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species
- (2010) David J. Farrell et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci
- (2010) Shannon D. Putnam et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antibacterial activity of finafloxacin under different pH conditions against isogenic strains of Escherichia coli expressing combinations of defined mechanisms of fluoroquinolone resistance
- (2010) Nadine-C. Emrich et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009)
- (2010) David J. Farrell et al. JOURNAL OF INFECTION
- Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa
- (2010) N. Srinivas et al. SCIENCE
- De Novo Design of Antimicrobial Polymers, Foldamers, and Small Molecules: From Discovery to Practical Applications
- (2009) Gregory N. Tew et al. ACCOUNTS OF CHEMICAL RESEARCH
- AFN-1252, a FabI Inhibitor, Demonstrates a Staphylococcus-Specific Spectrum of Activity
- (2009) J. A. Karlowsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Ribosomal Mutations in Staphylococcus aureus Strains Identified through Selection with the Oxazolidinones Linezolid and Torezolid (TR-700)
- (2009) J. B. Locke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Stieglitz rearrangement of N,N-dichloro-β,β-disubstituted taurines under mild aqueous conditions
- (2009) Timothy P. Shiau et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Quaternary ammonium N,N-dichloroamines as topical, antimicrobial agents
- (2009) Charles Francavilla et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Quinolones: Action and Resistance Updated
- (2009) Karl Drlica et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity
- (2009) N. Ooi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms
- (2009) N. Ooi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infections
- (2009) I. A. Critchley et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of the siderophore monobactam BAL30072 against multiresistant non-fermenters
- (2009) S. Mushtaq et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Vancomycin and Oritavancin Have Different Modes of Action in Enterococcus faecium
- (2009) Gary J. Patti et al. JOURNAL OF MOLECULAR BIOLOGY
- Crystal structures of pyridine-4-aldehyde thiosemicarbazone perchlorate and trifluoromethane sulfonate
- (2009) A. I. Smolentsev et al. JOURNAL OF STRUCTURAL CHEMISTRY
- A Comparative Review of the Lipoglycopeptides: Oritavancin, Dalbavancin, and Telavancin
- (2009) Michael T Guskey et al. PHARMACOTHERAPY
- De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers
- (2009) S. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibitors of FabI, an Enzyme Drug Target in the Bacterial Fatty Acid Biosynthesis Pathway
- (2008) Hao Lu et al. ACCOUNTS OF CHEMICAL RESEARCH
- In Vitro Activities of the Rx-01 Oxazolidinones against Hospital and Community Pathogens
- (2008) L. Lawrence et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- R -01, a New Family of Oxazolidinones That Overcome Ribosome-Based Linezolid Resistance
- (2008) E. Skripkin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of the Quinolone WCK 771 against Recent U.S. Hospital and Community-Acquired Staphylococcus aureus Pathogens with Various Resistance Types
- (2008) S. S. Bhagwat et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Design at the atomic level: Design of biaryloxazolidinones as potent orally active antibiotics
- (2008) Jiacheng Zhou et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis and SAR of novel parenteral anti-pseudomonal cephalosporins: Discovery of FR264205
- (2008) Ayako Toda et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design at the atomic level: Generation of novel hybrid biaryloxazolidinones as promising new antibiotics
- (2008) Jiacheng Zhou et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antimicrobial Activities of Twenty Lysine-Peptoid Hybrids against Clinically Relevant Bacteria and Fungi
- (2008) Trine S. Ryge et al. CHEMOTHERAPY
- Dalbavancin
- (2008) Vanessa R Anderson et al. DRUGS
- Oritavancin Exhibits Dual Mode of Action to Inhibit Cell-Wall Biosynthesis in Staphylococcus aureus
- (2008) Sung Joon Kim et al. JOURNAL OF MOLECULAR BIOLOGY
- PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
- (2008) R. Singh et al. SCIENCE
- N-Chloro-2,2-dimethyltaurines: a new class of remarkably stable N-chlorotaurines
- (2008) Lu Wang et al. TETRAHEDRON LETTERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started